The University of Notre Dame Australia

ResearchOnline@ND
Medical Papers and Journal Articles

School of Medicine

2014

Case series of elective instrumented posterior lumbar spinal fusions
demonstrating a low incidence of venous thromboembolism
Benjamin Weber
Alexa Seal
University of Notre Dame Australia, alexa.seal@nd.edu.au

Joseph McGirr
University of Notre Dame Australia, joe.mcgirr@nd.edu.au

Kerin Fielding
University of Notre Dame Australia, kerin.fielding@nd.edu.au

Follow this and additional works at: https://researchonline.nd.edu.au/med_article
Part of the Medicine and Health Sciences Commons
This article was originally published as:
Weber, B., Seal, A., McGirr, J., & Fielding, K. (2014). Case series of elective instrumented posterior lumbar spinal fusions
demonstrating a low incidence of venous thromboembolism. ANZ Journal of Surgery, Early View (Online First).
http://doi.org/10.1111/ans.12702

This article is posted on ResearchOnline@ND at
https://researchonline.nd.edu.au/med_article/683. For more
information, please contact researchonline@nd.edu.au.

This is the peer reviewed version of the following article:
Weber Benjamin, Seal Alexa, McGirr Joe, Fielding Kerin. 2014 Case series of elective
instrumented posterior lumbar spinal fusions demonstrating a low incidence of venous
thromboembolism. ANZ Journal of Surgery, doi: 10.1111/ans.12702
which has been published in final form at
http://onlinelibrary.wiley.com/doi/10.1111/ans.12702/pdf
This article may be used for non-commercial purposes in accordance with Wiley Terms and
Conditions for self-archiving.

1

Case series of elective instrumented posterior lumbar spinal fusions demonstrating a low incidence
of venous thromboembolism

Benjamin Weber, Alexa Seal, Joe McGirr† and Kerin Fielding
University of Notre Dame, Sydney, New South Wales, Australia

† Corresponding author
School of Medicine – Sydney – Rural Clinical School
The University of Notre Dame Australia
PO Box 5050
Wagga Wagga, NSW
Australia, 2650
Email: joe.mcgirr@nd.edu.au
Phone number: (02) 8204 4110

Accepted for publication 27/04/14

2

Abstract
Introduction: Venous thromboembolism (VTE) is a significant cause of morbidity and mortality in orthopaedic
surgery. While specific guidelines exist for hip and knee arthroplasty, there is wide variation in VTE prophylaxis in
complex spinal surgery. This study sought to determine the incidence of VTE, and risk factors associated with VTE, in
patients undergoing elective instrumented posterior lumbar spinal fusion.
Methods: In a single-centre case series study, 107 consecutive patients undergoing elective lumbar spinal fusion were
evaluated for VTE by lower limb duplex ultrasonography and/or clinical observation, and where indicated, computed
tomography pulmonary angiogram (CTPA). The Caprini model for thrombosis risk factor assessment was
retrospectively applied to grade levels of VTE risk, which were compared with overall VTE incidence.
Results: All patients were operated on a spinal frame and received mechanical prophylaxis (thromboembolic deterrent
stockings and sequential calf-compression devices). Thirty-seven percent also received chemoprophylaxis with low
molecular weight heparin (LMWH). There was no significant relationship between LMWH use and protection from
VTE. Risk scores ≥3 (high/highest risk categories) were observed in 96.2% of patients. Four (3.7%) patients
encountered a VTE complication (all with no chemoprophylaxis), either deep vein thrombosis (1.9%) or pulmonary
embolism (1.9%). No patient sustained an epidural haematoma.
Conclusion: Although patients undergoing elective instrumental posterior lumbar spinal fusion are at high risk of
developing VTE, the actual incidence of VTE in these patients is low. Our data support the use of mechanical
prophylaxis with thromboembolic deterrent stockings and sequential calf-compression devices to prevent VTE in these
patients.

Keywords: DVT, PE, spinal surgery, thromboprophylaxis, VTE
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Introduction
Venous thromboembolism (VTE) is a postoperative complication that manifests as either deep vein thrombosis (DVT)
or pulmonary embolism (PE). Approximately 30,000 people are hospitalised in Australia each year as a consequence of
VTE, and an estimated 2,000 die as a direct result.1 VTE prevention has been widely acknowledged both internationally
and within Australia as a prominent issue amongst hospitalised patients and thus represents a key opportunity to
improve patient safety.1
VTE is the most common complication following major joint surgery.2 Whilst there are clear guidelines for
VTE prophylaxis in hip and knee arthroplasty, there is a lack of consensus for elective spinal surgery. Patients
undergoing spinal surgery are not dissimilar to other orthopaedic surgical patients. They endure periods of extended
recumbence and limited mobility after a major operative intervention that may predispose them to thromboembolic
disease.3 Recently, a VTE risk score applied to patients undergoing spinal surgery has established that this is a group of
patients at high risk of VTE.4
The reported incidence of VTE in elective spinal surgery varies. For DVT, the incidence has been reported to
range from 0%5 to 26.5%6, while for PE it varies from 0%5 to 18%7. Factors contributing to the variation include
differences in prophylactic regimes, the nature of the surgery included and post-operative VTE surveillance methods.
Prophylactic measures discussed within the literature include (alone or in combination): thromboembolic deterrent
stockings (TEDS), sequential calf-compression devices (SCD), inferior vena cava filters (IVCF) and anticoagulant
medication. The variation in scientific studies examining VTE has led to uncertainty regarding thromboprophylaxis.3
In light of the lack of consensus regarding prophylaxis in spinal surgery, an investigation was carried out using
a prospectively collected database to review the incidence of VTE and prophylactic regimes in 107 consecutive patients
undergoing elective posterior instrumented spinal fusions by a single surgeon in rural New South Wales, Australia.

Methods
A database of 107 consecutive patients who underwent elective posterior instrumented lumbar spinal fusion was
reviewed. Patients were diagnosed with degenerative spondylosis and/or spondylolisthesis and had, in addition, one or
more of the following indications for surgery: spinal canal stenosis, lumbar instability, facet joint disease or
degenerative disc disease.
All patients were operated on by a single orthopaedic surgeon from July 2008 to July 2013. Surgery was
conducted at two hospitals: the Wagga Wagga Base Hospital, a 220 bed public regional referral hospital, and Calvary
Health Care Riverina, a 100 bed private hospital.
All patients were operated on in a prone position using a spinal frame. Patients underwent laminectomy and
insertion of pedicle screws (linked with rods) under image intensifier guidance. Harvested bone graft was applied with
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Actifuse™ to the appropriately prepared lateral gutters. Rhizolysis, foraminotomy and discectomy were undertaken as
required.
Each patient was placed on a VTE prophylactic regime involving pre-operative application of below the knee
TEDS and SCD. SCD were applied in the anaesthetic bay over the TEDS and were activated at the time the patient was
positioned on the spinal frame. They were temporarily disconnected for transfer to the recovery unit where they were
reactivated. SCD continued to operate until patient mobilisation. Patients underwent early post-operative mobilisation
(day 1 or 2 post surgery). A group of patients (n=40) was also placed on low molecular weight heparin (LMWH) 4-6
hours postoperatively. There were no clear-cut selection criteria for the application of chemoprophylaxis. During the
time period reported on herein, the surgeon discontinued the use of chemoprophylaxis due to the conflicting evidence in
the literature and concern regarding possible complications arising from the use of chemoprophylaxis. This change in
practice took some time to disseminate amongst the members of the health care teams. All patients were observed for
clinical evidence of VTE and two thirds were screened for DVT on day 4 or day 5 post surgery with duplex ultrasound.
A CT pulmonary angiogram (CTPA) was performed on all patients with clinical signs and/or symptoms suggestive of
PE.
In addition to the presence of DVT or PE for each patient, data were collected regarding age, gender, body
mass index (BMI), past medical and surgical history, previous spinal surgery, past history of VTE disease, medication
use, levels of spinal fusion, operation time, units of blood transfused, use of LMWH, time to mobilisation and
complications. The Caprini model8 for thrombosis risk factor assessment was retrospectively applied to grade the level
of VTE risk for each patient.
Statistical analyses were performed using SPSS Statistics Standard Edition 20 software (IBM, New York, NY,
USA). Pearson’s chi-square test was used for categorical variables, and independent samples t-tests were used for
continuous variables. All tests were two-sided, and a p-value <0.05 was set for statistical significance. Mean (standard
deviation) was reported for values with a normal distribution; otherwise median with range was reported.
Ethics approval was granted by the Human Research Ethics Committee of The University of Notre Dame,
Australia.

Results
Mean patient age was 58 (± 12) years with a range of 23 to 82 years. Ninety-one percent of the studied population was
over 40 years of age. Fifty-eight percent of patients were female. Mean BMI was 29.8 (± 6.1) with 83.2% having a BMI
≥25, and 47.7% a BMI ≥30. Of the cohort, 48.5% had had previous lumbar spinal surgery.
The private hospital hosted 58.9% of the operations performed. Average operating time was 279 minutes, with
a range of 162 to 426 minutes. Between one and seven spinal levels were fused (median two levels). A blood
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transfusion was administered in 38.3% of patients, with an average of 3.4 (± 1.7) units of packed cells transfused in
these patients. All patients in this case series were followed up for a minimum of three months post surgery. No patient
developed an epidural haematoma.
Mobilisation before day 3 took place in 91.6% of patients. All patients wore TEDS and SCD, while 37% also
received postoperative LMWH and 69.2% received a duplex ultrasound. Figure 1 depicts the change in the pattern of
use of LMWH over the studied period, which reflects the change in the practice of the surgeon described earlier. Eight
patients underwent CTPA scanning for suspected PE.
Risk factors for each patient were calculated to produce an overall VTE risk score based on the Caprini model
(Table 1). On reviewing the risk factors for VTE development in the patient population, 3.7% were at moderate risk,
41.1% were at high risk and 55.1% were at highest risk (Table 2). No patient fell within the low risk category because
all patients underwent surgery with an operation time of greater than 45 minutes, which automatically places them
above low risk.
From a total of 107 patients, only four (3.7%) had only one risk factor for VTE disease (the length of surgery
itself), while 18 patients (16.8%) had two risk factors, and the remaining 85 patients (79.4%) had more than two risk
factors. Only two patients (1.9%) developed distal DVTs and two other patients (1.9%) developed PEs, with a total
VTE incidence of 3.7% in the studied population. One patient who developed a DVT had an incarcerated inguinal
hernia surgically repaired two days after the spinal fusion operation. The DVT was detected five days after the hernia
operation. One of the patients with a PE received tranexamic acid intra-operatively. None of these patients had a
relevant medical history, hormone replacement therapy or oral contraceptive pill use, present of previous malignancy or
history of VTE.
A comparison was undertaken between the groups who did and did not receive LMWH post-operatively. There
were no differences between groups in gender, age, BMI, levels of spinal fusion, time to mobilisation or units of blood
transfused. All patients sustaining a VTE event had not received LMWH, but this was not statistically significant. There
was a statistically significant difference in the VTE investigation rate between the two groups (p=0.006). The group
receiving LMWH had a VTE investigation rate of 57.5% compared with an 82.1% rate in the no-LMWH group.

Discussion
The results of the present study have shown that patients undergoing complex elective spinal surgery are at high risk of
VTE. The incidence of VTE in these patients was, however, low (four cases in 107), equivalent to a rate of 3.7%.
Although there is variability in rates of VTE reported in the literature for patients undergoing spinal surgery, the
incidence of cases has generally been reported to be low. Nine recently published journal articles involving case series
studies (Table 3) reported incidence rates between 0% and 26.5%, with a mean of 2.65%. Larger retrospective studies
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(Table 4) have also found the incidence of VTE to be relatively low (0.1% - 0.45%). The reported incidence of VTE in
these studies was probably underestimated, as asymptomatic VTE was unlikely to have been coded and therefore
included. 9
Only one previous study incorporated a comparable group and method of surveillance as the present study. It
was carried out by Yoshioka et al.10 and included 90 patients who underwent elective instrumented posterior lower
thoracic or lumbar fusion for degenerative disease. This study also used mechanical VTE prophylaxis (TEDS and SCD),
although no patients received chemoprophylaxis. Both studies included methods to screen for and definitively detect a
VTE, however the technologies used differed between studies, with Yoshioka et al. using an additional screening tool
(lung perfusion scintigraphy) and a more comprehensive imaging tool if VTE was suspected (multidetector CT
venography). The incidence of VTE was found to be higher in Yoshioka et al. (13.3%) with eight distal DVTs, two
proximal DVTs and two PEs. It should be noted that 16.7% of patients in the study underwent post-operative bed rest
for greater than seven days and, in addition, there was a longer mean operating time (327.7 minutes). The more
extensive technology used in this study may have also contributed to a higher detection rate of VTE.
Raj and Marshall11 have described the array of local, general, pharmacological and physiological factors that
put patients at an increased risk of developing a VTE. Though the Caprini model risk score may be a valuable tool in
assessing individual risk factors, only one other case series looking at VTE incidence in spinal surgery has made use of
it (Table 2). This study, conducted by Al-Dujaili et al.4, included a higher proportion of low risk patients than the
current study. Nevertheless, the majority of patients were found to be at high or very high risk and like the present study
had a relatively low incidence of VTE (0.6%).
Analysis of the current database demonstrated that, over the time period of the study, there was a change in the
pattern of use of LMWH. This provided two patient groups for comparison: one group that received LMWH and
another group that had not. Although all cases of VTE in the current series occurred in patients not receiving LMWH,
the difference in VTE rate between the two groups was not statistically significant. There may have been additional
factors that contributed to the occurrence of VTE in two of the four patients. One VTE event occurred after a
subsequent operation for an incarcerated inguinal hernia, and another occurred following administration of tranexamic
acid inter-operatively, which may have caused an increased risk12. It is possible that chemoprophylaxis in addition to
mechanical prophylaxis provides some clinical benefit, particularly in high risk patients, however this study was too
small to draw this conclusion.
The current literature is also inconclusive as to whether LMWH should be given to patients undergoing spinal
surgery in addition to mechanical thromboprophylaxis. It is well documented that LMWH can increase the risk of
developing an epidural haematoma. Gerlach et al.13 found that the risk of epidural haematoma was nearly eightfold
greater than the risk of PE. Ozturk et al.14 have emphasised the importance of spinal surgeons carefully assessing the
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risk of using chemoprophylaxis for VTE prevention, and Sansome et al.15 have concluded that the risk of VTE in spinal
surgery is low, and, therefore, the risks of pharmacological prophylaxis outweigh its benefits. In this study, haematoma
was not recorded as a post-operative complication in any of the patients.
The limitations of this study include its nature as a case series. Furthermore, not all patients received a duplex
ultrasound, and, therefore, there may have been asymptomatic DVTs that were not diagnosed, leading to an
underestimate of VTE incidence. Although retrospective application of the Caprini model risk scores may have led to
incomplete patient risk scoring, due to the unavailability of some patient data, this would have only led to an
underestimate of the VTE risk of the studied population. Pre-operative screening for VTE was not performed in this
study. Finally, there was no randomisation involved in the use of LMWH and this limits the conclusions that can be
drawn from a comparison of the groups.
There may still be a substantial number of surgeons who do not employ VTE prophylaxis in spinal surgery.2, 9
A review of the literature and the findings from the current study lead to the conclusion that there is a high risk of VTE
in patients undergoing complex spinal surgery. The overall incidence of VTE is, however, low. This suggests that
currently employed mechanical prophylactic regimes are effective. Whether or not LMWH should be added to the
prophylactic regime is a complex issue, because of the risk of epidural haematoma and the limited evidence of
additional positive benefit.
There is a lack of clear and specific guidelines for VTE prophylaxis in elective spinal surgery. The VTE
prophylaxis guidelines in Australia, provided by the National Health and Medical Research Council (NHMRC) state
that all studies considered were either inconclusive or underpowered and, therefore, do not make a recommendation1.
According to data obtained from the Australian Institute of Health and Welfare19, 11 450 spinal fusions were conducted
in Australia during the 2009-2010 financial year. Given the potential high risk of VTE in the significant number of
patients undergoing spinal fusion in Australia each year, it would appear advisable to consider the use of aggressive
mechanical prophylaxis in all such patients. A large, comprehensive randomised controlled trial is required to address
the issue of the need for additional VTE chemoprophylaxis.
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Table 1 - VTE risk factors in patients undergoing elective instrumented posterior lumbar spinal fusion as assessed with
the Caprini model risk score4, 8
Risk factor

Points†

Number of patients

Percentage of population

affected (n=107)

(%)

Overweight and obese (BMI ≥25)

1

89

83

Age 41 - 60 years

1

45

42

Relevant medical history (i.e. IBD,

1

13

12

HRT or OCP use

1

9

8

Age 61 - 75 years

2

45

42

Mobilised after day 3

2

9

8

Present or previous malignancy

2

6

6

Major operation (>45 min)

2

107

100

Age >75 years

3

7

6

Past history of VTE

3

5

5

COPD or AMI)

†Point allocation followed the criteria outlined in Caprini et al. 8
BMI, body mass index; IBD, inflammatory bowel disease; COPD, chronic obstructive pulmonary disease; AMI, acute
myocardial infarct; HRT, hormone replacement therapy; OCP, oral contraceptive pill; VTE, venous thromboembolism
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Table 2 - Patient distribution according to venous thromboembolism (VTE) risk factor score4, 8
Risk factor score

0-1

2

3-4

5+

Level of risk

Low

Moderate

High

Highest

VTE incidence† (%)

2

10 - 20

20 - 40

40 - 80

Percentage in studied population (%)

-

3.7

41.1

55.1

Al-Dujaili et al.4 cohort (%)

-

31.6

55.0

13.4

†Without any prophylaxis
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Table 3 - Case series and case-control studies on VTE in spinal surgery
Study

Design

Year

Yoshioka et al.10

Prospective

2013

Sample

VTE event

VTE Rate

VTE

(%)

cases

Prophylaxis

DVT + PE

13.3

12

TEDS + SCD

Size
90

Method of VTE

Method of VTE Surveillance

Procedure Performed

US + lung scintigraphy ± CT

Posterior instrumented spinal

venography (if VTE clincally

fusion

suspected)
Al-Dujaili et al.

4

Prospective

2012

158

DVT

0.6

†

1

TEDS + LMWH ± SCD

Clinical + US

Spinal surgery excludes day
procedures but includes 24%
cervical

Takahashi et al.
Sansone et al.

15

7

Prospective

2012

100

DVT + PE

19.0

19

TEDS + SCD

CT

Decompression or fusion

Meta-analysis

2010

2838

DVT + PE

1.5

43

None or mechanical or

US or venography + CT or V/Q

Spinal surgery not limited to

aspirin or LMWH or

scan

fusion surgery

Clinical ± CT

Complex spinal surgery includes

warfarin
Ozturk et al.14

Retrospective

2010

129

PE

1.5

2

IVC filter + TEDS + SCD

trauma and anterior approaches
193

PE

4.2

8

Mechanical

Clinical ± CT

Complex spinal surgery includes
trauma and anterior approaches

Glotzbecker et
al.

3

Nicol et al.

Systematic

2009

1238

DVT + PE

2.8

35

Not specified

Not specified

Lumbar spinal fusion

2009

143

DVT + PE

1.4

2

SCD + TEDS

Clinical from records

Lumbar spinal fusion

142

DVT + PE

0

0

SCD + TEDS +

Clinical from records

Lumbar spinal fusion

Review
5

Retrospective

aspirin/heparin
Schizas et al.
Oda et al.6

16

Prospective

2008

244

PE

2.5

6

TEDS + LMWH

Clinical ± spiral CT

Instrumented spinal fusions

Prospective

2000

49

DVT

26.5

13

None

Venography

Posterior lumbar surgery

Total
Mean

5324

141
2.65

† Three epidural haematomas (1.8%)
VTE, venous thromboembolism; DVT, deep vein thrombosis; PE, pulmonary embolism; TEDS, thromboembolic deterrent stockings; SCD, sequential calf-compression devices; LMWH, low molecular
weight heparin; IVC, inferior vena cava; US, ultrasound; CT, computer tomography; V/Q, ventilation perfusion.
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Table 4 - Retrospective large medical database studies on VTE in spinal surgery
Study

Design

Year

Sample

VTE event

size
Masuda et al.

17

Senders et al.

18

Retrospective

2012

35524

PE

VTE rate

VTE

Method of VTE

Method of VTE

(%)

cases

prophylaxis

surveillance

0.1

35

Mechanical

Unknown

database
Retrospective

Procedure performed

Lumbar spinal surgery with
mostly posterior approach

2012

2107419

PE

0.2

5058

Not specified

database

Not specified

Lumbar fusions including for

(medical codes

spinal cord injury and fractures

used)
Fang et al.

9

Retrospective

2011

80183

DVT + PE

0.45

†

359

database

None or

Not specified

mechanical or

(medical codes

pharmacological

used)

Spinal fusions

or combination
Total
Mean rate

2223126

5452
0.25

† rate of epidural haematoma was 1.1%
VTE, venous thromboembolism; DVT, deep vein thrombosis; PE, pulmonary embolism.
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